This project will compare the performance of non-contrast morphologic MRI relative to CT and pulmonary function tests in characterizing disease severity in cystic fibrosis patients. The goal of this work is to develop an MR-specific scoring system for tracking disease severity and response to therapy in cystic fibrosis patients. A robust and sensitive MRI biomarker for disease progression would help facilitate evaluation of the many therapeutic options being developed for cystic fibrosis without the need for ionizing radiation.
This project was funded by:
The term of this project was: June 2010 to June 2011
The number of subjects scanned during this project was: 15